Lupin launches Ganirelix Acetate Injection, 250 mcg/0.5 ml

PSM News /

Feb 15,2024

 

Mumbai: Lupin Limited announced the launch of Ganirelix Acetate Injection, 250 mcg/0.5 ml, single-dose prefilled syringe, after receiving approval from the United States Food and Drug Administration (US FDA).

 

Ganirelix Acetate Injection, 250 mcg/0.5 ml, single-dose prefilled syringe is a generic equivalent to the reference listed drug (RLD), Ganirelix Acetate Injection, 250 mcg/0.5 ml, of Organon USA LLC. It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.

 

Ganirelix Acetate Injection had estimated annual sales of $87 million in the US (IQVIA MAT December 2023).

 

Source: Pharma